Search Orphan Drug Designations and Approvals
-
Generic Name: | 2-(3-amino-6-chloroquinolin-2-yl)-propan-2-ol |
---|---|
Date Designated: | 04/17/2017 |
Orphan Designation: | Treatment of congenital ichthyosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Aldeyra Therapeutics 131 Hartwell Avenue Suite 320 Lexington, Massachusetts 02421 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-